MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Harvard Bioscience Total Assets 2011-2026 | HBIO
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Harvard Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 137 M | 145 M | 162 M | 156 M | 165 M | 169 M | 109 M | 108 M | 120 M | 136 M | 135 M | 133 M | 127 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 169 M | 108 M | 139 M |
Quarterly Total Assets Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78 M | 80.1 M | 79.8 M | 127 M | 131 M | 129 M | 133 M | 137 M | 140 M | 143 M | 146 M | 145 M | - | - | 158 M | 162 M | 154 M | 154 M | 151 M | 156 M | 156 M | 156 M | 156 M | 165 M | 165 M | 165 M | 165 M | 169 M | 169 M | 169 M | 169 M | 109 M | 109 M | 109 M | 109 M | 108 M | 108 M | 108 M | 108 M | 120 M | 120 M | 120 M | 120 M | 136 M | 136 M | 136 M | 136 M | 135 M | 135 M | 146 M | 135 M | 133 M | 133 M | 133 M | 133 M | 127 M | 127 M | 127 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 169 M | 78 M | 135 M |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
25.8 B | $ 20.66 | 1.27 % | $ 10.5 B | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 205.09 | 1.16 % | $ 59 B | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
26.7 M | $ 8.15 | -7.6 % | $ 164 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
30.3 B | $ 80.67 | -0.38 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
609 M | $ 42.59 | 1.96 % | $ 2 B | USA |
 |
electroCore
ECOR
|
16.1 M | $ 5.15 | 6.19 % | $ 28.4 K | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 84.98 | 2.36 % | $ 4.28 B | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 10.02 | -8.29 % | $ 409 M | USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 83.38 | -0.63 % | $ 16.6 B | USA |
 |
ICU Medical
ICUI
|
4.2 B | $ 152.88 | 1.7 % | $ 3.73 B | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 114.49 | 0.43 % | $ 5.55 B | USA |
 |
InfuSystem Holdings
INFU
|
99.4 M | $ 8.9 | -0.11 % | $ 184 M | USA |
 |
iRhythm Technologies
IRTC
|
931 M | $ 188.16 | 0.41 % | $ 5.87 B | USA |
 |
Isoray
ISR
|
341 M | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 5.79 | 3.02 % | $ 264 M | USA |
 |
LeMaitre Vascular
LMAT
|
552 M | $ 85.05 | 1.55 % | $ 1.91 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 138.18 | 0.8 % | $ 7.36 B | USA |
 |
Intuitive Surgical
ISRG
|
18.7 B | $ 586.15 | -1.03 % | $ 208 B | USA |
 |
Merit Medical Systems
MMSI
|
2.42 B | $ 93.33 | 1.83 % | $ 5.43 B | USA |
 |
Microbot Medical
MBOT
|
8.33 M | $ 2.19 | 3.55 % | $ 22.3 M |  Israel |
 |
Nephros
NEPH
|
11.9 M | $ 5.07 | -1.74 % | $ 52.7 M | USA |
 |
Milestone Scientific
MLSS
|
9.8 M | $ 0.29 | 2.24 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.35 B | $ 23.52 | 2.53 % | $ 4.05 B | USA |
 |
OraSure Technologies
OSUR
|
480 M | $ 2.65 | 5.38 % | $ 197 M | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 41.83 | 4.47 % | $ 138 M | USA |
 |
Predictive Oncology
POAI
|
4.97 M | $ 6.85 | 3.24 % | $ 37.4 M | USA |
 |
Pulse Biosciences
PLSE
|
59.2 M | $ 14.71 | -3.26 % | $ 707 M | USA |
 |
Repligen Corporation
RGEN
|
2.83 B | $ 165.12 | -2.32 % | $ 9.2 M | USA |
 |
ResMed
RMD
|
5.1 B | $ 250.85 | 1.07 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
399 M | $ 24.91 | -1.97 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
10.1 B | $ 260.64 | 0.52 % | $ 25.7 B | USA |
 |
Stereotaxis
STXS
|
41.9 M | $ 2.57 | -1.35 % | $ 207 M | USA |
 |
Retractable Technologies
RVP
|
161 M | $ 0.76 | -0.53 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
510 M | $ 22.43 | 1.08 % | $ 1.1 B | USA |
 |
Utah Medical Products
UTMD
|
135 M | $ 58.5 | 1.39 % | $ 212 M | USA |
 |
Teleflex Incorporated
TFX
|
7.1 B | $ 110.0 | -13.07 % | $ 5.15 B | USA |
 |
West Pharmaceutical Services
WST
|
3.64 B | $ 274.0 | -1.62 % | $ 20 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.75 B | $ 12.53 | 1.25 % | $ 2.55 B | USA |